Chlamydia Trachomatis Infection Of Genital Tract Research Articles

The potential protective role of the combination of IL-22 and TNF-α against genital tract Chlamydia trachomatis infection

Th22 cells are a novel class of lymphocytes characterized by the secretion of both IL-22 and TNF-α. In summary, Th22 cells have little or no direct impact on other immune cells, but exert selective effects on epithelia. It is not known, however, whether Th22 cells play a role in genital mucosal immunity. Here, we demonstrate that IL-22 and TNF-α synergistically induce several immunomodulatory molecules, such as the antimicrobial peptide mBD-2 (murine β-defensin 2) and the antimicrobial chemokines CXCL-9, -10, and -11 in primary murine oviduct epithelial cells (MOECs). The induction of innate immunity is relevant in an in vitro infection model, in which MOECs stimulated with Th22 cell supernatants or recombinant IL-22 and TNF-α effectively inhibit the growth of Chlamydia trachomatis and maintain the survival of the epithelia compared with IL-22 or TNF-α alone. In summary, we demonstrate that the Th22 cell cytokines IL-22 and TNF-α play important roles in genital tract infection. The potential for Th22 cell cytokines to modulate innate immune mediators may lead to the development of new topical agents to treat and/or prevent immune-mediated sexually transmitted diseases (STDs). In summary, we demonstrate that IL-22 and TNF-α represent a potent, synergistic cytokine combination for inducing genital mucosal immunity.

A prospective study of asymptomatic Chlamydia trachomatis in Barbadian women

A prospective study to determine the prevalence of asymptomatic female genital tract Chlamydia trachomatis infection was performed on 167 women at the Queen Elizabeth Hospital, Barbados, West Indies and at a private clinic. The ELISA (Microtrak, chlamydia EIA, Syva, CA) method was used to detect Chlamydia trachomatis antigen. Nineteen (11.4% 95% CI 6.5-16.3) women were found positive. The efficacy of a single 1 gram dose of azithromycin given orally to 18 patients was tested after 4 weeks. One patient who was pregnant was given 500 mg erythromycin four times daily orally for 1 week. Only six patients (including the pregnant patient) reported for follow up. All six repeat swabs were negative for C. trachomatis antigen. The prevalence of 11.4% asymptomatic chlamydial infection in endocervical swabs in Barbadian women is in agreement with a previous study which reported a prevalence of 18.4% +/7.8%. Patient compliance was assured, using a single dose of azithromycin. It was found to be as effective as doxycyline and ciprofloxacin as reported by other workers.

Proliferative response to conserved epitopes of the Chlamydia trachomatis and human 60-kilodalton heat-shock proteins by lymphocytes from women with salpingitis

Our objective was to determine whether an upper genital tract Chlamydia trachomatis infection sensitizes lymphocytes to heat-shock protein epitopes expressed in both the human and chlamydial 60 kd heat-shock protein. Peripheral blood mononuclear cells were isolated from women with or without a prior documented salpingitis and tested for their ability to proliferate in response to the recombinant C. trachomatis heat-shock protein and to five synthetic peptides corresponding to conserved epitopes expressed in both the human and chlamydial heat-shock proteins. Among 22 healthy women with no history of chlamydial infections or salpingitis and 10 women seen for complaints other than a C. trachomatis infection, none had positive lymphocyte responses to any of the peptides and only one responded to the chlamydial heat-shock protein. Among nine women with a single episode of salpingitis none responded to the chlamydial heat-shock protein and one exhibited a positive lymphocyte response to a single peptide. This woman was also positive for C. trachomatis in the cervix. In contrast, among the 10 women with two or more episodes of salpingitis four (40%) had proliferation in response to the chlamydial heat-shock protein and five (50%) had positive lymphocyte responses to one of the peptides; two of these women also had C. trachomatis detected in their cervices. In women with a history of C. trachomatis upper genital tract infections, infection with C. trachomatis or other microorganisms can induce a lymphocyte proliferative response to the chlamydial 60 kd heat-shock protein and to epitopes present in the human heat-shock protein.